glp 1 crohn's Frontiers GLP-1 Use in Crohn's Disease:

Using these findings, they estimated a 5-year number needed to harm, between 1349 and 1562 (Table 2)

Premature discontinuation due to side effects or cost barriers significantly limits effectiveness

Side effect profile differences Sublingual drops tend to produce milder GI side effects compared to injections, particularly during the dose escalation phase

Clinical studies consistently show that a significant portion of lost weight returns after discontinuing GLP-1 therapy, because these medications manage a chronic condition rather than cure it

These drugs are getting attention for their ability to help people lose weight, but they arent magic

This article examines the current evidence, biological mechanisms, and clinical implications of GLP-1 receptor agonists in relation to cognitive function and dementia risk